Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response. (Q50910869)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

1 reference

Emmanuelle Tancrede-Bohin

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

27

Rüdiger Eming

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Natacha Colliou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Damien Picard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Frédérique Caillot

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sébastien Calbo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Stéphanie Le Corre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Annick Lim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Brigitte Lemercier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Brigitte Le Mauff

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Maud Maho-Vaillant

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Serge Jacquot

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Christophe Bedane

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Philippe Bernard

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Frédéric Caux

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Catherine Prost

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Emmanuel Delaporte

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Marie-Sylvie Doutre

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Brigitte Dreno

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Nathalie Franck

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Saskia Ingen-Housz-Oro

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Olivier Chosidow

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Christine Pauwels

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Catherine Picard

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Jean-Claude Roujeau

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Michèle Sigal

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Isabelle Templier

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Michael Hertl

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Michel D'Incan

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Pascal Joly

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Philippe Musette

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

language of work or name

English

0 references

publication date

1 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

Science Translational Medicine

25 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

175ra30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23467561%20AND%20SRC:MED&resulttype=core&format=json

Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Immunosuppressive therapy for autoimmune bullous diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Rituximab therapy in lupus nephritis: current clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Current therapy of the pemphigus group

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

A single cycle of rituximab for the treatment of severe pemphigus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Regulatory B cells as inhibitors of immune responses and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Pathophysiological aspects of memory B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Mechanisms of killing by anti-CD20 monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005166